TCS, HDFCBANK, SBI Liquid Fund (G)
Bal Pharma Ltd.
Bal Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | A.G.M. & Audited Results & Final Dividend |
| 10 08 2021 | Quarterly Results |
| 11 11 2021 | Quarterly Results |
| 10 02 2022 | Quarterly Results |
| 09 03 2022 | Inter alia consider approval of scheme of amalgamation between Bal Pharma Ltd and its wholly owned subsidiary i.e Golden Drugs Private Ltd , subject to the approval of applicable statutes and shareholders of the Company. |
| 13 04 2022 | Preferential Issue of shares |
| 30 05 2022 | Final Dividend & Audited Results |
| 11 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results(Cancelled) |
| 06 02 2023 | Quarterly Results |
| 29 05 2023 | Audited Results & Final Dividend |
| 11 08 2023 | Quarterly Results & A.G.M. |
| 08 11 2023 | Employees Stock Option Plan & Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
News
No News data available
